Dr. Nabeel Hamoui

Dr. Nabeel Hamoui
Nabeel Hamoui, MD, returns to Hernando County from Chicago, Illinois, where he has practiced medicine since 2009. Dr. Hamoui received his medical degree from Duke University School of Medicine in Durham, North Carolina, where he also served as a Fellow for the National Institutes of Health. Dr. Hamoui also holds a Master of Business Administration (MBA) degree from the Kellogg School of Management at Northwestern University. Dr. Hamoui completed an internship in general and urologic surgery, a residency in diagnostic radiology, a fellowship in vascular and interventional radiology, and a residency in urology all at Northwestern Memorial Hospital, Chicago. He also served as Chief Resident in Urology from July 2017 to June 2018. He is certified by the American Board of Radiology. Dr. Hamoui is the recipient of the 2018 Humanism in Medicine Award at Northwestern Memorial Hospital and in 2017 he placed first for clinical research at the annual Charles Huggins Resident Essay Contest of the Chicago Urologic Society. He is a member of the American Urological Association, Society of Interventional Radiology, and the Radiology Society of North America. He and his wife have two children. He enjoys traveling, reading, exercise and chess.

Languages Spoken:

English, Arabic

Medical School:

Duke University School of Medicine in Durham, North Carolina

Residency:

Northwestern Memorial Hospital, Chicago

Fellowship:

Northwestern Memorial Hospital, Chicago

Undergraduate:

Duke University, North Carolina

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only